Bayer unveils a faster-acting aspirin

May 29, 2011

Bayer AG is looking for a speedy remedy for stagnant aspirin sales. The company is introducing a reformulated aspirin today that works in half the time of its regular aspirin.

Bayer says it needed to revitalize the brand and target younger customers to improve its 14.6 percent .

Scientists at Bayer Consumer Care’s Morristown, N.J., headquarters worked for five years to address consumers’ top complaint: The aspirin doesn’t work fast enough.

Bayer Advanced Aspirin was tested in multiple sites on dental patients who had just had wisdom teeth extracted. The company said 500 milligrams of the new aspirin started working in 16 minutes and brought “meaningful pain relief’’ in 49, on average, compared with 100 minutes for the same dose of regular aspirin. Bayer is arranging to publish its research. It has not tested the aspirin against other pain relievers.

In 1988, was approved in low doses to prevent heart attacks and strokes. As a result, “people have kind of forgotten about the fact that is our heritage,’’ said Barton Warner, a Bayer executive.

Analyst Linda Bannister expects Bayer Advance to be a tough sell: Sales of store brand aspirins are growing steadily.

shares

Related Stories

Recommended for you

Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in RI

February 14, 2018
A treatment program for opioid addiction launched by the Rhode Island Department of Corrections was associated with a significant drop in post-incarceration drug overdose deaths and contributed to an overall drop in overdose ...

Heroin vaccine blocks lethal overdose

February 14, 2018
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Study shows NIH spent >$100 billion on basic science for new medicines

February 12, 2018
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.

Opioid use increases risk of serious infections

February 12, 2018
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

Placebo pills prescribed honestly help cancer survivors manage symptoms

February 9, 2018
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers at the University of Alabama at Birmingham and Harvard Medical School have ...

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
not rated yet May 29, 2011
I wonder why the work on a drug which costs pennies, unless they think they can patent the modified drug and get people to pay a premium price.

49 minutes versus 100 minutes.

Ibuprophen works in about 40 minutes, 20 to 30 minutes if ingested in a liquid gel. I don't see a large market for aspirin for pain relief, but it will continue to be the drug of choice to reduce clots and for the initial treatment of a clot.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.